Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF.

Bean GR, Bryson AD, Pilie PG, Goldenberg V, Baker JC Jr, Ibarra C, Brander DM, Paisie C, Case NR, Gauthier M, Reynolds PA, Dietze E, Ostrander J, Scott V, Wilke LG, Yee L, Kimler BF, Fabian CJ, Zalles CM, Broadwater G, Tlsty TD, Seewaldt VL.

Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6834-41.

2.

Breast cancer epigenetics: normal human mammary epithelial cells as a model system.

Hinshelwood RA, Clark SJ.

J Mol Med (Berl). 2008 Dec;86(12):1315-28. doi: 10.1007/s00109-008-0386-3. Review.

PMID:
18716754
3.

Implication of the INK4a/ARF locus in gastroenteropancreatic neuroendocrine tumorigenesis.

Simon B, Lubomierski N.

Ann N Y Acad Sci. 2004 Apr;1014:284-99. Review.

PMID:
15153447
4.

Genetic and epigenetic changes in mammary epithelial cells may mimic early events in carcinogenesis.

Tlsty TD, Crawford YG, Holst CR, Fordyce CA, Zhang J, McDermott K, Kozakiewicz K, Gauthier ML.

J Mammary Gland Biol Neoplasia. 2004 Jul;9(3):263-74. Review.

PMID:
15557799
5.

The regulation of INK4/ARF in cancer and aging.

Kim WY, Sharpless NE.

Cell. 2006 Oct 20;127(2):265-75. Review.

6.

Promoter hypermethylation as an epigenetic component in Type I and Type II endometrial cancers.

Risinger JI, Maxwell GL, Berchuck A, Barrett JC.

Ann N Y Acad Sci. 2003 Mar;983:208-12. Review.

PMID:
12724225
7.
8.

DNA methylation and breast carcinogenesis.

Widschwendter M, Jones PA.

Oncogene. 2002 Aug 12;21(35):5462-82. Review.

9.

Gene-promoter hypermethylation as a biomarker in lung cancer.

Belinsky SA.

Nat Rev Cancer. 2004 Sep;4(9):707-17. Review.

PMID:
15343277
10.

Nutritional modulation of terminal end buds: its relevance to breast cancer prevention.

Hilakivi-Clarke L.

Curr Cancer Drug Targets. 2007 Aug;7(5):465-74. Review.

PMID:
17691906
11.

Modeling INK4/ARF tumor suppression in the mouse.

Berger JH, Bardeesy N.

Curr Mol Med. 2007 Feb;7(1):63-75. Review.

PMID:
17311533
12.
13.

The silence of the genes: epigenetic disturbances in haematopoietic malignancies.

Hackanson B, Guo Y, L├╝bbert M.

Expert Opin Ther Targets. 2005 Feb;9(1):45-61. Review.

PMID:
15757481
14.

Epigenome remodelling in breast cancer: insights from an early in vitro model of carcinogenesis.

Locke WJ, Clark SJ.

Breast Cancer Res. 2012 Nov 15;14(6):215. doi: 10.1186/bcr3237. Review.

15.

Clinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic Cancer.

Tang B, Li Y, Qi G, Yuan S, Wang Z, Yu S, Li B, He S.

Sci Rep. 2015 Sep 4;5:13563. doi: 10.1038/srep13563. Review.

16.

Intrauterine breast development and the mammary myoepithelial lineage.

Jolicoeur F.

J Mammary Gland Biol Neoplasia. 2005 Jul;10(3):199-210. Review.

PMID:
16807800
17.

Loss of chromosomal integrity in human mammary epithelial cells subsequent to escape from senescence.

Tlsty TD, Romanov SR, Kozakiewicz BK, Holst CR, Haupt LM, Crawford YG.

J Mammary Gland Biol Neoplasia. 2001 Apr;6(2):235-43. Review.

PMID:
11501583
18.

The search for biomarkers of aging: next stop INK4a/ARF locus.

Dimri GP.

Sci Aging Knowledge Environ. 2004 Nov 3;2004(44):pe40. Review.

PMID:
15525836
Items per page

Supplemental Content

Support Center